Breakthroughs

Millions of people are now living with COVID-19 and their long-term outcomes are unknown. Northwestern's Dr. Jeffrey Linder says more research studies on this group are needed to provide better information about COVID-19 care before, during, and beyond the hospital.

A team of Northwestern scientists have come together from across disciplines to develop a COVID-19 antibody test designed for at-home use. Elizabeth McNally, MD, PhD, is part of the team working on this test to determine prior exposure to the virus.

Although COVID-19 doesn't necessarily discriminate, some communities are far more susceptible to the disease. People who are black or African-American are more likely to contract the virus - and to die from it. Clyde Yancy, MD, discusses reasons for these outcomes and the need to fully address health care disparities in America.

Monitoring patients and frontline health care workers for symptoms of COVID-19 could get much easier with a small wireless sensor developed by scientists at Northwestern and the Shirley Ryan AbilityLab. Northwestern’s John A. Rogers explains. 

While the world anxiously awaits a vaccine for COVID-19, some physicians on the front lines are trying new or repurposed therapies in an effort to help COVID patients. Dr. Benjamin Singer, a Northwestern physician-scientist, discusses his experiences in the ICU during this time and his recently published letter warning against the use of unproven therapies.

This is an update to the Jan. 28, 2020 episode about Northwestern's Karla Satchell's effort to lead an investigation into the structure biology of the components of COVID-19. The goal is to ultimately understand how to stop it from replicating in human cells through a medication or vaccine.

In mid-March, the early days of Chicago's COVID-19 outbreak, older adults with multiple chronic conditions didn’t think the disease would affect them and reported not changing their behaviors, according to the results of a Northwestern Medicine. Michael Wolf led this study and explains the results.

Judith Moskowitz, PhD, MPH, is a social psychologist and professor of Medical Social Sciences at Feinberg who studies the impact of positive emotion on health-related and other life stress. She discusses her research and things you can do to increase positivity during the COVID-19 pandemic.

As an epidemiologist and infectious disease physician, Chad Achenbach, MD, MPH, has shared his expertise on a variety of global public health crises such as Ebola and Zika outbreaks. In this episode, he sheds light on the global emergence, epidemiology and response to COVID-19.

Abel Kho, MD, is the director of the new Institute for Augmented Intelligence in Medicine at Feinberg (now called the Institute for Artificial Intelligence in Medicine). He discusses his vision for the institute and how AI can enhance healthcare.